Table 2.
Variable | Recurrence-free survival | Overall survival | ||||
---|---|---|---|---|---|---|
|
|
|||||
Multivariate | Multivariate | |||||
|
|
|||||
Univariate P | HR (95% CI) | P | Univariate P | HR (95% CI) | P | |
Age, yr | 0.133 | 0.122 | ||||
Gender (male vs female*) | 0.641 | 0.489 | ||||
Tumor size, cm | < 0.001 | 1.103 (1.004-1.212) | 0.042 | < 0.001 | 1.118 (1.005-1.243) | 0.040 |
Pathologic T stage | ||||||
T3+T4 vs T1+T2* | < 0.001 | 2.642 (1.564-4.463) | < 0.001 | < 0.001 | 2.767 (1.545-4.957) | 0.001 |
Fuhrman grade (3+4 vs 1+2*) | < 0.001 | 2.459 (1.472-4.108) | 0.001 | 0.004 | 2.138 (1.204-3.796) | 0.009 |
Necrosis (present vs absent*) | 0.018 | 1.145 (0.632-2.007) | 0.655 | 0.012 | 1.312 (0.684-2.517) | 0.413 |
ECOG PS (≥ 1 vs. 0*) | 0.001 | 1.587 (0.875-2.878) | 0.129 | 0.002 | 1.593 (0.818-3.100) | 0.171 |
Combination of IL-4 and IL-13a | 0.001 | 0.029 | 0.006 | 0.051 | ||
Either high vs both low* | 0.053 | 1.931 (0.929-4.015) | 0.078 | 0.417 | 1.435 (0.610-3.377) | 0.408 |
Both high vs both low* | < 0.001 | 2.277 (1.233-4.204) | 0.009 | 0.002 | 2.268 (1.163-4.423) | 0.016 |
HR = hazard ratio; CI = confidence interval; ECOG-PS = Eastern Cooperative Oncology Group performance status.
Reference group.
Overall P value is provided, and HR, 95% CI, and P values are provided for each level.